Brief: Recro Reports Fourth Quarter And Year End 2021 Financial Results

Societal CDMO

01/03/2022 22:31

March 1 (Reuters) - Recro Pharma Inc  REPH.O :
    * RECRO REPORTS FOURTH QUARTER AND YEAR END 2021 FINANCIAL
RESULTS
    * Q4 LOSS PER SHARE $0.04
    * SEES FY REVENUE ABOUT $90 MILLION TO $95 MILLION
    * REVENUES FOR QUARTER ENDED DECEMBER 31, 2021 WERE $22.3
MILLION
    * SEES FY NET LOSS TO BE IN RANGE OF $13.2 MILLION TO $11.2
MILLION

Source text for Eikon:  ID:nGNX4FVTRX 
Further company coverage:  REPH.O